Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164244238> ?p ?o ?g. }
- W3164244238 endingPage "556" @default.
- W3164244238 startingPage "546" @default.
- W3164244238 abstract "Rationale: Early empirical antimicrobial treatment is frequently prescribed to critically ill patients with coronavirus disease (COVID-19) based on Surviving Sepsis Campaign guidelines.Objectives: We aimed to determine the prevalence of early bacterial identification in intubated patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, as compared with influenza pneumonia, and to characterize its microbiology and impact on outcomes.Methods: A multicenter retrospective European cohort was performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation >48 hours were eligible if they had SARS-CoV-2 or influenza pneumonia at ICU admission. Bacterial identification was defined by a positive bacterial culture within 48 hours after intubation in endotracheal aspirates, BAL, blood cultures, or a positive pneumococcal or legionella urinary antigen test.Measurements and Main Results: A total of 1,050 patients were included (568 in SARS-CoV-2 and 482 in influenza groups). The prevalence of bacterial identification was significantly lower in patients with SARS-CoV-2 pneumonia compared with patients with influenza pneumonia (9.7 vs. 33.6%; unadjusted odds ratio, 0.21; 95% confidence interval [CI], 0.15-0.30; adjusted odds ratio, 0.23; 95% CI, 0.16-0.33; P < 0.0001). Gram-positive cocci were responsible for 58% and 72% of coinfection in patients with SARS-CoV-2 and influenza pneumonia, respectively. Bacterial identification was associated with increased adjusted hazard ratio for 28-day mortality in patients with SARS-CoV-2 pneumonia (1.57; 95% CI, 1.01-2.44; P = 0.043). However, no significant difference was found in the heterogeneity of outcomes related to bacterial identification between the two study groups, suggesting that the impact of coinfection on mortality was not different between patients with SARS-CoV-2 and influenza.Conclusions: Bacterial identification within 48 hours after intubation is significantly less frequent in patients with SARS-CoV-2 pneumonia than patients with influenza pneumonia.Clinical trial registered with www.clinicaltrials.gov (NCT04359693)." @default.
- W3164244238 created "2021-06-07" @default.
- W3164244238 creator A5005205127 @default.
- W3164244238 creator A5006917212 @default.
- W3164244238 creator A5007666743 @default.
- W3164244238 creator A5007900127 @default.
- W3164244238 creator A5010481236 @default.
- W3164244238 creator A5012201847 @default.
- W3164244238 creator A5012552377 @default.
- W3164244238 creator A5013002748 @default.
- W3164244238 creator A5013990412 @default.
- W3164244238 creator A5018007709 @default.
- W3164244238 creator A5018045666 @default.
- W3164244238 creator A5022718423 @default.
- W3164244238 creator A5029068860 @default.
- W3164244238 creator A5029770659 @default.
- W3164244238 creator A5029943377 @default.
- W3164244238 creator A5034004394 @default.
- W3164244238 creator A5036483909 @default.
- W3164244238 creator A5037174756 @default.
- W3164244238 creator A5042987943 @default.
- W3164244238 creator A5043346486 @default.
- W3164244238 creator A5046135818 @default.
- W3164244238 creator A5048903493 @default.
- W3164244238 creator A5048961308 @default.
- W3164244238 creator A5052265648 @default.
- W3164244238 creator A5053916099 @default.
- W3164244238 creator A5054165149 @default.
- W3164244238 creator A5057253914 @default.
- W3164244238 creator A5059045057 @default.
- W3164244238 creator A5062287721 @default.
- W3164244238 creator A5062938473 @default.
- W3164244238 creator A5064736877 @default.
- W3164244238 creator A5069139964 @default.
- W3164244238 creator A5069482005 @default.
- W3164244238 creator A5073194089 @default.
- W3164244238 creator A5077862644 @default.
- W3164244238 creator A5079884763 @default.
- W3164244238 creator A5083506378 @default.
- W3164244238 creator A5087103452 @default.
- W3164244238 creator A5087941499 @default.
- W3164244238 creator A5089682004 @default.
- W3164244238 creator A5091622740 @default.
- W3164244238 date "2021-09-01" @default.
- W3164244238 modified "2023-10-17" @default.
- W3164244238 title "Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial" @default.
- W3164244238 cites W1995615618 @default.
- W3164244238 cites W2019349925 @default.
- W3164244238 cites W2076298858 @default.
- W3164244238 cites W2166978186 @default.
- W3164244238 cites W2167944937 @default.
- W3164244238 cites W2207760002 @default.
- W3164244238 cites W2264767503 @default.
- W3164244238 cites W2528694892 @default.
- W3164244238 cites W2564915973 @default.
- W3164244238 cites W2904354111 @default.
- W3164244238 cites W2977322360 @default.
- W3164244238 cites W3007764760 @default.
- W3164244238 cites W3013671288 @default.
- W3164244238 cites W3024193040 @default.
- W3164244238 cites W3027918021 @default.
- W3164244238 cites W3030700284 @default.
- W3164244238 cites W3033735761 @default.
- W3164244238 cites W3037768701 @default.
- W3164244238 cites W3041831980 @default.
- W3164244238 cites W3042486011 @default.
- W3164244238 cites W3043029189 @default.
- W3164244238 cites W3043975336 @default.
- W3164244238 cites W3048393261 @default.
- W3164244238 cites W3080967360 @default.
- W3164244238 cites W3083290247 @default.
- W3164244238 cites W3096704753 @default.
- W3164244238 cites W3118419263 @default.
- W3164244238 cites W4205823937 @default.
- W3164244238 cites W4286662321 @default.
- W3164244238 doi "https://doi.org/10.1164/rccm.202101-0030oc" @default.
- W3164244238 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8491267" @default.
- W3164244238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34038699" @default.
- W3164244238 hasPublicationYear "2021" @default.
- W3164244238 type Work @default.
- W3164244238 sameAs 3164244238 @default.
- W3164244238 citedByCount "53" @default.
- W3164244238 countsByYear W31642442382021 @default.
- W3164244238 countsByYear W31642442382022 @default.
- W3164244238 countsByYear W31642442382023 @default.
- W3164244238 crossrefType "journal-article" @default.
- W3164244238 hasAuthorship W3164244238A5005205127 @default.
- W3164244238 hasAuthorship W3164244238A5006917212 @default.
- W3164244238 hasAuthorship W3164244238A5007666743 @default.
- W3164244238 hasAuthorship W3164244238A5007900127 @default.
- W3164244238 hasAuthorship W3164244238A5010481236 @default.
- W3164244238 hasAuthorship W3164244238A5012201847 @default.
- W3164244238 hasAuthorship W3164244238A5012552377 @default.
- W3164244238 hasAuthorship W3164244238A5013002748 @default.
- W3164244238 hasAuthorship W3164244238A5013990412 @default.
- W3164244238 hasAuthorship W3164244238A5018007709 @default.
- W3164244238 hasAuthorship W3164244238A5018045666 @default.
- W3164244238 hasAuthorship W3164244238A5022718423 @default.